SCHEMBL4188058

SCHEMBL4188058

CN(C(=O)c1c(F)cccc1F)c1cccc(C(=O)Nc2c(Br)cc(C(F)(C(F)(F)F)C(F)(F)F)cc2SC(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 3/20 0.35
MAPT P10636 3/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TLR8 Q9NR97 1/20 0.33
RORC P51449 2/20 0.32
KCNJ11 Q14654 2/20 0.32
KCNK2 O95069 1/20 0.32
KCNK10 P57789 1/20 0.32
EGFR P00533 1/20 0.32
MAPK14 Q16539 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183073 0.90 NR1H3 (0.40) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL13875608 0.89 MAPT (0.37) TLR7MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL1766932 0.87 TLR7 (0.36) TLR7MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL1766372 0.87 MAPT (0.36) TLR7MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL1766705 0.83 TLR7 (0.35) TLR7MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL4175359 0.79 MAPT (0.39) MAPTRAB9ANPC1KCNJ11RXFP1
SCHEMBL4181081 0.79 PTGS1 (0.47) MAPTSMN1; SMN2KDM4EALDH1A1HSD17B10
SCHEMBL13875611 0.78 MAPT (0.39) MAPTRAB9ANPC1KDM4EALDH1A1
SCHEMBL1767144 0.78 RXFP1 (0.40) MAPTRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL4192114 0.78 MEN1 (0.50) MAPTRAB9ANPC1SMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099204-A1 Amide derivative, insecticide containing the same and method for application thereof as insecticide MITSUI CHEMICALS, INC. (JP) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099204-A1 Amide derivative, insecticide containing the same and method for application thereof as insecticide CYP2E1, GSTA1, CYP2S1 TLR7 3194/4885MAPT 4640/4885RAB9A 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.